Modi Backs Stent Price Controls; More Drugs To Join List
Prime Minister Narendra Modi said he supports price control for stent products, weighing in on the debate ahead of the last phase of assembly elections in Uttar Pradesh.
Stents for coronary diseases will be available at Rs 8,000, a third of its actual price, after the National Pharmaceutical Pricing Authority (NPPA) imposed price control on February 28. Imported products will be available for Rs 27,000, a sixth of their real price. The price caps will benefit the middle class, Modi said at a campaign rally in Varanasi, on Saturday.
"I called the manufacturers of stents and discussed this issue,'' Modi said.
The price control had stoked fears of unavailability of coronary stents in the country.
The government agency will hold second round of meeting with manufacturers and importers to review stock positions and plans for next six months on Tuesday, NPPA tweeted.
NPPA to hold second round of meeting with stent manufacturers/ importers on 07/03/2017 to review stock positions and plans for next 6 months
March 3, 2017NPPA has begun posting on its websites the names of the hospitals who have been over-charging. The authority is also released a list of 24 hospitals for overcharging and non-disclosure of information to the patients. These hospitals did not disclose the name of the manufacturer, the brand and its specifications to the patients during billing.
The drug price regulator also notified through a gazette that non-compliance of pricing details would lead to prosecution under the Essential Commodities Act.
Modi said the government has reduced prices of 800 drugs, including those used for the treatment of Diabetes. “We have forced drug companies to sell drugs that cost Rs 30,000 per tablet at one point to sell them at Rs 3,000,” Modi added.
The NPPA also tweeted that it will meet on March 9 to consider price control on few more drugs.
Next Authority meeting of NPPA on March,09; Few more drugs to come under price control
March 5, 2017Also Read: Stent Price Cap Could Turn Away Rich Patients: Devi Shetty
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
